Annual CFI
$74.88 M
+$47.19 M+170.41%
December 31, 2024
Summary
- As of March 10, 2025, VERV annual cash flow from investing activities is $74.88 million, with the most recent change of +$47.19 million (+170.41%) on December 31, 2024.
- During the last 3 years, VERV annual CFI has risen by +$313.97 million (+131.32%).
- VERV annual CFI is now at all-time high.
Performance
VERV Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$29.55 M
-$27.27 M-47.99%
December 1, 2024
Summary
- As of March 10, 2025, VERV quarterly cash flow from investing activities is $29.55 million, with the most recent change of -$27.27 million (-47.99%) on December 1, 2024.
- Over the past year, VERV quarterly CFI has stayed the same.
- VERV quarterly CFI is now -50.83% below its all-time high of $60.09 million, reached on March 31, 2022.
Performance
VERV Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$74.88 M
+$38.44 M+105.49%
December 1, 2024
Summary
- As of March 10, 2025, VERV TTM cash flow from investing activities is $74.88 million, with the most recent change of +$38.44 million (+105.49%) on December 1, 2024.
- Over the past year, VERV TTM CFI has stayed the same.
- VERV TTM CFI is now at all-time high.
Performance
VERV TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
VERV Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +170.4% | 0.0% | 0.0% |
| 3 y3 years | +131.3% | +349.7% | +156.8% |
| 5 y5 years | +686.9% | +349.7% | +156.8% |
VERV Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +131.3% | -50.8% | +117.5% | at high | +131.3% |
| 5 y | 5-year | at high | +131.3% | -50.8% | +113.9% | at high | +131.3% |
| alltime | all time | at high | +131.3% | -50.8% | +113.9% | at high | +131.3% |
Verve Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $74.88 M(+170.4%) | - | - |
| Dec 2024 | - | $29.55 M(-48.0%) | $74.88 M(+105.5%) |
| Sep 2024 | - | $56.81 M(+88.4%) | $36.44 M(-213.1%) |
| Jun 2024 | - | $30.15 M(-172.4%) | -$32.21 M(+9.8%) |
| Mar 2024 | - | -$41.63 M(+368.1%) | -$29.33 M(-205.9%) |
| Dec 2023 | $27.69 M(-117.8%) | -$8.89 M(-24.9%) | $27.69 M(-121.0%) |
| Sep 2023 | - | -$11.83 M(-135.8%) | -$131.73 M(-24.9%) |
| Jun 2023 | - | $33.02 M(+114.6%) | -$175.41 M(-12.6%) |
| Mar 2023 | - | $15.39 M(-109.1%) | -$200.66 M(+28.7%) |
| Dec 2022 | -$155.96 M | -$168.31 M(+203.2%) | -$155.96 M(+249.5%) |
| Sep 2022 | - | -$55.52 M(-813.4%) | -$44.63 M(-77.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $7.78 M(-87.0%) | -$201.43 M(+5.6%) |
| Mar 2022 | - | $60.09 M(-205.5%) | -$190.72 M(-20.2%) |
| Dec 2021 | -$239.10 M(+367.7%) | -$56.98 M(-73.2%) | -$239.10 M(+40.5%) |
| Sep 2021 | - | -$212.32 M(-1248.3%) | -$170.23 M(-532.4%) |
| Jun 2021 | - | $18.49 M(+57.8%) | $39.37 M(-181.9%) |
| Mar 2021 | - | $11.71 M(-1.5%) | -$48.05 M(-6.0%) |
| Dec 2020 | -$51.13 M(+300.7%) | - | - |
| Dec 2020 | - | $11.89 M(-537.3%) | -$51.13 M(-18.9%) |
| Sep 2020 | - | -$2.72 M(-96.1%) | -$63.01 M(+4.5%) |
| Jun 2020 | - | -$68.94 M(-898.0%) | -$60.30 M(-798.0%) |
| Mar 2020 | - | $8.64 M | $8.64 M |
| Dec 2019 | -$12.76 M | - | - |
FAQ
- What is Verve Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Verve Therapeutics?
- What is Verve Therapeutics annual CFI year-on-year change?
- What is Verve Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Verve Therapeutics?
- What is Verve Therapeutics quarterly CFI year-on-year change?
- What is Verve Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Verve Therapeutics?
- What is Verve Therapeutics TTM CFI year-on-year change?
What is Verve Therapeutics annual cash flow from investing activities?
The current annual CFI of VERV is $74.88 M
What is the all time high annual CFI for Verve Therapeutics?
Verve Therapeutics all-time high annual cash flow from investing activities is $74.88 M
What is Verve Therapeutics annual CFI year-on-year change?
Over the past year, VERV annual cash flow from investing activities has changed by +$47.19 M (+170.41%)
What is Verve Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of VERV is $29.55 M
What is the all time high quarterly CFI for Verve Therapeutics?
Verve Therapeutics all-time high quarterly cash flow from investing activities is $60.09 M
What is Verve Therapeutics quarterly CFI year-on-year change?
Over the past year, VERV quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Verve Therapeutics TTM cash flow from investing activities?
The current TTM CFI of VERV is $74.88 M
What is the all time high TTM CFI for Verve Therapeutics?
Verve Therapeutics all-time high TTM cash flow from investing activities is $74.88 M
What is Verve Therapeutics TTM CFI year-on-year change?
Over the past year, VERV TTM cash flow from investing activities has changed by $0.00 (0.00%)